ELI LILLY AND COMPANY
Last · NYSE$1179.39+19.39 (+1.67%)stale · yahoo · 149h ago
Market cap$1.05T891.7M sh
P/E · TTM39.6fwd 25.0 · eps 29.81
Beta0.51vs S&P 500
Div yield0.60%annual · TTM
52w range
$712.05$1292.65
Volume91.1Ksession
| Revenue | $79.7B |
|---|---|
| Operating income | $33.6B |
| Net income | $26.7B |
| Operating margin | 42.2% |
| Net margin | 33.5% |
| Return on equity | 78.8% |
| Period | TTM 2026-06-30 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2024-02-21
- Current Ratio Low
Red flags
- Current Ratio Low — Current ratio 0.94
Upcoming earnings
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
$9.87
Est. revenue
22.2B
Earnings transcripts
- Motley Fool
Eli Lilly (LLY) Q2 2026 Earnings Call Transcript
ELI LILLY AND COMPANY
- Issuer webcast
2025 conference transcript
ELI LILLY AND COMPANY
- Issuer webcast
Webcasts & Presentations
ELI LILLY AND COMPANY
- Issuer webcast
Earnings call transcript
ELI LILLY AND COMPANY
- Issuer webcast
Earnings call transcript
ELI LILLY AND COMPANY
- Issuer webcast
Earnings call transcript
ELI LILLY AND COMPANY
Press & signals
- Satelight
The lifesaving secret hidden inside a horseshoe crab's blue blood
Documents
FormReporting forFiledFlags